Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,557 | -9,788 | -5,078 | -19,479 | -14,893 |
| Depreciation Amortization | 840 | 575 | 295 | 1,351 | 1,049 |
| Accounts receivable | -241 | N/A | -1,000 | N/A | N/A |
| Other Working Capital | -321 | -1,125 | -652 | -2,189 | -1,833 |
| Other Operating Activity | 3,311 | 2,250 | 2,203 | 4,735 | 2,824 |
| Operating Cash Flow | $-11,968 | $-8,088 | $-4,232 | $-15,582 | $-12,853 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -458 | -377 | -104 | -131 | -203 |
| Net Acquisitions | N/A | N/A | N/A | 3,008 | 3,008 |
| Investing Cash Flow | $-458 | $-377 | $-104 | $2,877 | $2,805 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 717 | 718 | N/A | N/A | N/A |
| Common Stock Issued | 23,061 | 23,000 | 23,412 | 9,975 | 9,975 |
| Other Financing Activity | -1,000 | -1,000 | -1,000 | -1,000 | -1,000 |
| Financing Cash Flow | $22,778 | $22,718 | $22,412 | $8,975 | $8,975 |
| Beginning Cash Position | 6,733 | 6,733 | 6,733 | 10,463 | 10,463 |
| End Cash Position | 17,085 | 20,986 | 24,809 | 6,733 | 9,390 |
| Net Cash Flow | $10,352 | $14,253 | $18,076 | $-3,730 | $-1,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,968 | -8,088 | -4,232 | -15,582 | -12,853 |
| Capital Expenditure | -458 | -377 | -104 | -224 | -203 |
| Free Cash Flow | -12,426 | -8,465 | -4,336 | -15,806 | -13,056 |